Delving into the Latest Updates on Shenyang Dashan Pharmaceutical Technology Co., Ltd. with Synapse

Overview

Tags

Skin and Musculoskeletal Diseases

Immune System Diseases

Nervous System Diseases

Small molecule drug

Disease domain score

A glimpse into the focused therapeutic areas

Technology Platform

Most used technologies in drug development

Targets

Most frequently developed targets

Disease Domain	Count

Nervous System Diseases	1
Immune System Diseases	1

Top 5 Drug Type	Count

Small molecule drug	1

Top 5 Target	Count

COX(Cyclooxygenases)	1

主要目的：以药代动力学参数作为主要终点评价指标，分别比较在空腹/餐后状态下口服受试制剂替米沙坦氨氯地平片（持证商：沈阳达善医药科技有限公司）与参比制剂替米沙坦氨氯地平片（持证商：Boehringer Ingelheim International GmbH，商品名：Twynsta®）后在健康受试者体内的药代动力学行为，评价两种制剂的生物等效性。次要目的：观察受试制剂替米沙坦氨氯地平片和参比制剂替米沙坦氨氯地平片在健康受试者中的安全性。

[Translation]

Main purpose: Using pharmacokinetic parameters as the primary endpoint evaluation index, compare the oral administration of the test preparation Telmisartan Amlodipine Tablets (licensee: Shenyang Dashan Pharmaceutical Technology Co., Ltd.) and The pharmacokinetic behavior of the reference preparation Telmisartan and Amlodipine Tablets (licensee: Boehringer Ingelheim International GmbH, trade name: Twynsta®) in healthy subjects was evaluated to evaluate the bioequivalence of the two preparations. . Secondary purpose: To observe the safety of the test preparation Telmisartan Amlodipine Tablets and the reference preparation Telmisartan Amlodipine Tablets in healthy subjects.

Start Date26 Apr 2024

Sponsor / Collaborator

Shenyang Dashan Pharmaceutical Technology Co., Ltd.

CTR20230036 / Active, not recruitingPhase 1

培比洛芬缓释片在中国健康受试者中药代动力学临床试验研究

[Translation] Clinical trial study on the pharmacokinetics of pebiprofen sustained-release tablets in Chinese healthy subjects

（1）评价单次给药和多次给药的安全性；（2）考察单次给药和多次给药的药代动力学特征。

[Translation]

(1) Evaluate the safety of single and multiple administrations; (2) Investigate the pharmacokinetic characteristics of single and multiple administrations.

Start Date30 Jan 2023

Sponsor / Collaborator

Daewon Pharmaceutical Co., Ltd.

[+1]

100 Clinical Results associated with Shenyang Dashan Pharmaceutical Technology Co., Ltd.

Login to view more data

0 Patents (Medical) associated with Shenyang Dashan Pharmaceutical Technology Co., Ltd.

Login to view more data

100 Deals associated with Shenyang Dashan Pharmaceutical Technology Co., Ltd.

Login to view more data

100 Translational Medicine associated with Shenyang Dashan Pharmaceutical Technology Co., Ltd.

Login to view more data

Corporation Tree

Boost your research with our corporation tree data.

login

or

view full example data

Boost your research with our corporation tree data.

Pipeline

Pipeline Snapshot as of 26 Nov 2024

The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3

Phase 1

1

Login to view more data